How do you pay?

How to pay the least

Cash price

$2,170+ for 30 tablets

Pharmacies pay about this for Rhapsido; you’d pay more.

  1. Ask your pharmacy for Rhapsido’s cash price, and one or two other pharmacies too.
  2. Rhapsido’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify Novartis Patient Assistance Foundation (NPAF). Patients must have a household income of less than or equal to $81,760 (for a household size of two) to be considered for NPAF. Or call 1-800-277-2254.

See if you qualify 

No generic is sold yet.

Compare every option

Question
Brand nameRhapsido
Authorized genericremibrutinib
Regular genericremibrutinib
What you’d pay
At least$2,170for 30 tablets; pharmacies pay this
Not soldThere isn’t one
Not soldNone sold yet
Same as Rhapsido?
The original
–
–

Brand nameThe maker’s card

RHAPSIDO Co-Pay Plus

Savings card from Novartis

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a prescription

Sign up on support.rhapsido.com 

Or call 1-877-427-7436. See the offer on rhapsido.com

In the maker’s words

“Eligible patients with private insurance may pay as little as $0 every year.”

From the maker’s offer on rhapsido.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Rhapsido itself, from the same company, sold without the brand name, and usually for less. For now Rhapsido is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

RHAPSIDO® is a kinase inhibitor indicated for adult patients who remain symptomatic despite use of H1 antihistamine for the treatment of:

  • chronic spontaneous urticaria.
  • symptomatic dermographism.

Source: the FDA label for Rhapsido (Novartis Pharmaceuticals Corporation), October 6, 2026. Full label on DailyMed 

Good to know